Wei-wei H. Pan
Jiaxing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Isocucurbitacin B targets STAT3 to induce ferroptosis and promote anti-PD1 immunotherapy responses in breast cancer.
Journal: International journal of surgery (London, England)
Published: July 28, 2025
DCAF13: a positive regulator of colon cancer cell proliferation via the AMER2/ Wnt/β-catenin pathway.
Journal: NPJ precision oncology
Published: July 23, 2025
Nucleolar protein DCAF13 promotes non-small cell lung cancer cell proliferation via facilitating rDNA transcription and ribosome biogenesis.
Journal: The Journal of biological chemistry
Published: January 27, 2025
Discovery of a highly potent, N-terminal domain-targeting degrader of AR-FL/AR-V7 for the treatment of prostate cancer.
Journal: European journal of medicinal chemistry
Published: September 05, 2024
DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway.
Journal: Cellular and molecular life sciences : CMLS
Published: April 21, 2024
S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway.
Journal: Oncogene
Published: February 28, 2023
Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study.
Journal: Therapeutic advances in gastroenterology
Published: December 15, 2022
Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study.
Journal: Frontiers in immunology
Published: November 26, 2022
Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study.
Journal: Cancer medicine
Published: October 28, 2022
CpG-binding protein CFP1 promotes ovarian cancer cell proliferation by regulating BST2 transcription.
Journal: Cancer gene therapy
Published: December 16, 2021
DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression.
Journal: Cancer science
Published: December 14, 2021
Last Updated: 09/26/2026